EP3383916 - Bibliographic data
ANTICORPS ANTI-CD73 ET LEURS UTILISATIONS
| Last update | 29/05/2025 |
|---|---|
| Legal status | Brevet délivré |
| Origin | Euro-PCT |
| (73) Holder |
I-Mab Biopharma US Limited 9801 Washingtonian Blvd, Suite 710
Gaithersburg, MD 20878
États-Unis d'Amérique
|
|---|---|
| (72) Inventors |
Zhengyi WANG Suite 802, West Tower
OmniVision Tech Park
88 Shangke Road
Pudong New District
Shanghai 201210
Chine
Lei FANG Suite 802, West Tower
OmniVision Tech Park
88 Shangke Road
Pudong New District
Shanghai 201210
Chine
Bingshi GUO Suite 802, West Tower
OmniVision Tech Park
88 Shangke Road
Pudong New District
Shanghai 201210
Chine
Jingwu ZANG Suite 802, West Tower
OmniVision Tech Park
88 Shangke Road
Pudong New District
Shanghai 201210
Chine
|
| (74) Agent |
Mail recipient
OFFICE FREYLINGER SA BP 48 - 234, ROUTE D'ARLON,
8001
STRASSEN
Luxembourg
|
| (21) Request number | EP18733153.3 |
|---|---|
| (22) Request date | 23/01/2018 |
| (11) Publication number | EP3383916 |
|---|---|
| Publication date | 23/02/2022 |
| (54) Title of the invention | ANTICORPS ANTI-CD73 ET LEURS UTILISATIONS |
|---|---|
| (51) International classification | C07K 16/28, C07K 16/40, A61K 39/395, A61P 35/00, G01N 33/53, G01N 33/574, A61K 39/00 |
| International classification (before reform) | None |
| Claimed priority |
(31) Number: PCT/CN2017/072445 |
|---|---|
| Initial application | None |
| Divisional application | EP22150866.6 /EP4050030 None |
| Expected annuity | Annuity: 9 - Amount: 175 € - Due date 02/02/2026 |
|---|---|
| Last annuity | Annuity: 8 - Payment date 30/12/2024 |
| Publication | None |
|---|---|
| History | Publication de la délivrance du brevet européen - Legal date 23/02/2022 Constitution de mandataire pour un dossier - Legal date 12/05/2022 Mise à jour des données du registre en ligne - Legal date 05/07/2022 |